About
Jennifer L. Davis is Chief Executive Officer, Health Care at Procter & Gamble, a position she has held since 2022. She previously served at P&G as President, Feminine Care, President, Global Feminine Care, and Vice President, Feminine Care, North America, over a 30-plus-year career, and has announced plans to retire from P&G in June 2026. Ms. Davis has served as an AbbVie director since 2023 and sits on the Nominations & Governance committee.
Roles
AbbVie Inc.
Chief Executive Officer, Health Care, Procter & Gamble · Current role
2023–present
Procter & Gamble
Chief Executive Officer, Health Care
2022 - present
Procter & Gamble
President, Feminine Care
2019 - 2022
Procter & Gamble
President, Global Feminine Care
2018 - 2019
Procter & Gamble
Vice President - Feminine Care, North America
2016 - 2018
Director Compensation
FY 2025
Fees Earned or Paid in Cash
$122,917
Restricted Stock Unit Awards
$224,961